Ownership history in B Group, Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which B Group, Inc. reported a position in SPYRE THERAPEUTICS INC (SYRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 100,000 | — | 0% | 2.42% | $3.3M | $32.76 |
| 2025 Q3 | ADDED | 100,000 | +20,000 | +25.0% | 1.23% | $1.7M | $16.76 |
| 2025 Q2 | ADDED | 80,000 | +10,000 | +14.3% | 0.92% | $1.2M | $14.97 |
| 2025 Q1 | ADDED | 70,000 | +20,000 | +40.0% | 0.97% | $1.1M | $16.14 |
As of 2025 Q4 — sorted by position size